Dr. Kalpana Rajanala is a scientific and medical writer at Ocugen, Inc., Malvern, Pennsylvania,
United States. She received a PhD in Cell/Cellular and Molecular Biology from the National Institute of Immunology in 2012. She received her master's degree in biotechnology from the Birla Institute
of Technology and Science in 2006. She worked as a
research associate at the National Institute of Immunology from April 2012 to
October 2014 and as a post-doctoral fellow at the University of Goettingen,
Germany, from November 2014 to March 2015. She served as a research scholar and
postdoctoral research associate from December 2015 to August 2019 at Memorial
Sloan Kettering Cancer Center. She was a research associate at Thomas Jefferson
University Hospitals from August 2019 to March 2023. She is a scientist,
editor, and scientific and medical writer. Her work in the field of
biochemistry, cell, and molecular biology for over 17 years was specifically
targeted toward identifying the novel signal transduction pathways that occur
in the cell that would assist in comprehending various disease processes such
as cancer, laminopathies, ocular and neurodegenerative diseases, etc., and thereby
ultimately lead to the development of new treatment modalities.
Dr. Kalpana Rajanala is a scientific and medical writer at Ocugen, Inc., Malvern, Pennsylvania,
United States. She received a PhD in Cell/Cellular and Molecular Biology from the National Institute of Immunology in 2012. She received her master's degree in biotechnology from the Birla Institute
of Technology and Science in 2006. She worked as a
research associate at the National Institute of Immunology from April 2012 to
October 2014 and as a post-doctoral fellow at the University of Goettingen,
Germany, from November 2014 to March 2015. She served as a research scholar and
postdoctoral research associate from December 2015 to August 2019 at Memorial
Sloan Kettering Cancer Center. She was a research associate at Thomas Jefferson
University Hospitals from August 2019 to March 2023. She is a scientist,
editor, and scientific and medical writer. Her work in the field of
biochemistry, cell, and molecular biology for over 17 years was specifically
targeted toward identifying the novel signal transduction pathways that occur
in the cell that would assist in comprehending various disease processes such
as cancer, laminopathies, ocular and neurodegenerative diseases, etc., and thereby
ultimately lead to the development of new treatment modalities.